- Home
- INO vs SUNS Comparison
INO vs SUNS Comparison
Compare INO & SUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INO | SUNS |
|---|---|---|
| Founded | 1979 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.6M | 134.6M |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | INO | SUNS |
|---|---|---|
| Price | $1.75 | $9.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $9.00 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 1.7M | 108.8K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | ★ 12.45% |
| EPS Growth | N/A | ★ 1112.46 |
| EPS | N/A | ★ 1.09 |
| Revenue | $182,337.00 | ★ $19,384,703.00 |
| Revenue This Year | N/A | $174.58 |
| Revenue Next Year | $21,214.02 | $60.45 |
| P/E Ratio | ★ N/A | $8.83 |
| Revenue Growth | N/A | ★ 2540.16 |
| 52 Week Low | $1.30 | $7.80 |
| 52 Week High | $2.98 | $14.72 |
Technical Indicators
Market Signals| Indicator | INO | SUNS |
|---|---|---|
| Relative Strength Index (RSI) | 37.10 | 46.17 |
| Support Level | $2.11 | $9.31 |
| Resistance Level | $2.37 | $10.13 |
| Average True Range (ATR) | 0.19 | 0.30 |
| MACD | -0.05 | -0.06 |
| Stochastic Oscillator | 6.16 | 41.06 |
Price Performance
Historical ComparisonAbout INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About SUNS Sunrise Realty Trust Inc.
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.